https://reverse-it-trial.com/
PhaseBio introduces REVERSE-IT [https://reverse-it-trial.com/] (Rapid and SustainEd ReVERSal of TicagrElor - Intervention Trial), a pivotal Phase 3 tiral designed to study the reversal of the antiplatelet effects of ticagrelor with bentracimab in patients who present with uncontrolled major or life-threatening bleeding or who require surgery or an invasive procedure. For more information, please visit https://clinicaltrials.gov/ct2/show/NCT04286438.
PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular and cardiopulmonary diseases.
PhaseBio is located in Malvern, PA and San Diego, CA.